Private Capital Group, LLC Atea Pharmaceuticals, Inc. Transaction History
Private Capital Group, LLC
- $133 Million
- Q2 2022
A detailed history of Private Capital Group, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 156 shares of AVIR stock, worth $486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
156Holding current value
$486% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVIR
# of Institutions
110Shares Held
48.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY9.12MShares$28.5 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$23.7 Million20.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$15.3 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$15.2 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.76 Million2.68% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $260M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...